European Society of Mycobacteriology - Instituto Nacional de Saúde ...
European Society of Mycobacteriology - Instituto Nacional de Saúde ...
European Society of Mycobacteriology - Instituto Nacional de Saúde ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
PP-73<br />
QUANTIFERON ® -TB GOLD IN-TUBE TEST USED IN PRAGUE<br />
PATIENTS LISTED IN THE NATIONAL TUBERCULOSIS REGISTER<br />
Havelkova, Marta 1 , Bartu, Vaclava 2 , Kubin, Milan 3<br />
1 - National Institute <strong>of</strong> Public Health – NRL for mycobacteria<br />
2 - Charles University , Faculty <strong>of</strong> Medicine, Faculty Thomayer Hospital<br />
3 - Prague Hygiene Institute<br />
In 2006-2007, 65 (29.0%) <strong>of</strong> 224 patients registered in the A15, A16 and A18/19 categories (58.5%, 32.3% and 9.2% <strong>of</strong> all<br />
patients, respectively) were assessed using both the QuantiFERON – TB Gold In-Tube (QFT) method and the tuberculin<br />
skin test (TST) with 2 TU PPD.<br />
After stimulation with tuberculosis-specific antigens, a low level <strong>of</strong> interferon-gamma (IFG) production (< 0.35 IU) was<br />
found in 18 (27.7%) patients and mo<strong>de</strong>rate or high levels (> 0.35 IU) in the remaining 47 (72.3%) patients. After incubation<br />
with a non-specific mitogen, a low level <strong>of</strong> IFG production was recovered in 13 (20%) individuals, with mo<strong>de</strong>rate or<br />
high levels being found in the remaining 52 (80%) patients.<br />
The TST revealed low levels <strong>of</strong> skin infiltrate reaction (0-5 mm) in 25 patients (39.1%) and mo<strong>de</strong>rate or high levels <strong>of</strong> skin<br />
reaction (range 6 - > 30 mm) in the remaining 39 individuals (60.9%).<br />
The high proportion <strong>of</strong> low reagent levels in both the QFT and tuberculin skin tests can be explained by a high number <strong>of</strong><br />
ol<strong>de</strong>r patients, comorbidity with malignant tumours, diabetes or general fatigue in pre-terminal patients, and the immune<br />
systém insufficiency related to these factors.<br />
^<br />
This presentation was fully supported by project KAN 200520702 <strong>of</strong> the Grant Agency <strong>of</strong> Czech Aca<strong>de</strong>my <strong>of</strong> Sciences (GAAV CqR).<br />
<strong>European</strong> <strong>Society</strong> <strong>of</strong> <strong>Mycobacteriology</strong> | 30 th Annual Congress | July 2009 | Porto - Portugal<br />
145